Table 2.
Sarcoidosis rate | Non-sarcoidosis rate | Rate ratio (95% CI) | |
---|---|---|---|
| |||
Overall | 17.3 | 12.6 | 1.37 (1.24 – 1.52) |
| |||
Sex | |||
Females | 22.0 | 13.8 | 1.60 (1.40 – 1.82) |
Males | 12.2 | 11.5 | 1.06 (0.91 – 1.25) |
| |||
Ages | |||
20–34 | 11.5 | 9.8 | 1.18 (0.74 – 1.88) |
35–49 | 9.7 | 5.0 | 1.94 (1.50 – 2.54) |
50–64 | 16.2 | 11.8 | 1.38 (1.17 – 1.64) |
65–79 | 25.7 | 21.1 | 1.22 ( 1.01 – 1.46) |
80+ | 48.8 | 42.9 | 1.14 (0.88 – 1.48) |
| |||
Calendar year | |||
1987–1991 | 15.5 | 9.8 | 1.57 (1.10 – 2.28) |
1992–1996 | 13.4 | 11.5 | 1.16 (0.86 – 1.57) |
1997–2001 | 14.3 | 11.8 | 1.22 (0.93 – 1.59) |
2002–2006 | 23.0 | 14.0 | 1.64 (1.34 – 2.03) |
2007–2011 | 16.8 | 13.1 | 1.28 (1.04 – 1.58) |
2012–2015 | 18.3 | 13.5 | 1.36 (1.09 – 1.69) |
| |||
Years after sarcoidosis diagnosis | |||
0–4 | 15.9 | 10.2 | 1.56 (1.26 – 1.94) |
5–9 | 15.1 | 11.0 | 1.37 (1.09 – 1.73) |
10–14 | 18.6 | 14.2 | 1.31 (1.05 – 1.64) |
15–19 | 21.8 | 12.7 | 1.71 (1.33 – 2.21) |
20–24 | 17.2 | 14.4 | 1.19 (0.88 – 1.61) |
25–29 | 18.5 | 15.8 | 1.17 (0.80 – 1.71) |
CI, confidence interval